No Data
Analysts Offer Insights on Healthcare Companies: Tenaya Therapeutics (TNYA), Bolt Biotherapeutics (BOLT) and Amarin (AMRN)
Bolt Biotherapeutics' Restructuring Faces Potential Setbacks: A Closer Look
Bolt Biotherapeutics GAAP EPS of -$0.40, Revenue of $1.14M
Stifel Maintains Bolt Biotherapeutics(BOLT.US) With Hold Rating, Maintains Target Price $1.5
H.C. Wainwright Maintains Bolt Biotherapeutics(BOLT.US) With Hold Rating
H.C. Wainwright Reaffirms Their Hold Rating on Bolt Biotherapeutics (BOLT)
No Data
No Data